Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-po… Read more
Market Cap & Net Worth: Teva Pharmaceutical Industries Limited (TEVJF)
Teva Pharmaceutical Industries Limited (PINK:TEVJF) has a market capitalization of $17.18 Billion ($17.18 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #1190 globally and #915 in its home market, demonstrating a -0.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Teva Pharmaceutical Industries Limited's stock price $14.75 by its total outstanding shares 1164638689 (1.16 Billion).
Teva Pharmaceutical Industries Limited Market Cap History: 2015 to 2025
Teva Pharmaceutical Industries Limited's market capitalization history from 2015 to 2025. Data shows change from $65.88 Billion to $17.18 Billion (-12.77% CAGR).
Teva Pharmaceutical Industries Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Teva Pharmaceutical Industries Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.92x
Teva Pharmaceutical Industries Limited's market cap is 0.92 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
11.25x
Teva Pharmaceutical Industries Limited's market cap is 11.25 times its annual earnings
10.29x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $56.48 Billion | $21.90 Billion | $329.00 Million | 2.58x | 171.66x |
| 2017 | $17.47 Billion | $22.39 Billion | -$16.27 Billion | 0.78x | N/A |
| 2018 | $18.69 Billion | $18.85 Billion | -$2.15 Billion | 0.99x | N/A |
| 2019 | $10.19 Billion | $16.89 Billion | -$999.00 Million | 0.60x | N/A |
| 2020 | $10.95 Billion | $16.66 Billion | -$3.99 Billion | 0.66x | N/A |
| 2021 | $10.07 Billion | $15.88 Billion | $417.00 Million | 0.63x | 24.16x |
| 2022 | $10.41 Billion | $14.93 Billion | -$2.35 Billion | 0.70x | N/A |
| 2023 | $10.04 Billion | $15.85 Billion | -$559.00 Million | 0.63x | N/A |
| 2024 | $18.38 Billion | $16.54 Billion | -$1.64 Billion | 1.11x | N/A |
| 2025 | $17.18 Billion | $18.68 Billion | $1.53 Billion | 0.92x | 11.25x |
Competitor Companies of TEVJF by Market Capitalization
Companies near Teva Pharmaceutical Industries Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Teva Pharmaceutical Industries Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Sandoz Group AG (OTCQX:SDZXF): Ranked #1124 globally with a market cap of $17.13 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #1124 | Sandoz Group AG | OTCQX:SDZXF | $17.13 Billion | $41.36 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
Teva Pharmaceutical Industries Limited Historical Marketcap From 2015 to 2025
Between 2015 and today, Teva Pharmaceutical Industries Limited's market cap moved from $65.88 Billion to $ 17.18 Billion, with a yearly change of -12.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $17.18 Billion | -6.53% |
| 2024 | $18.38 Billion | +83.06% |
| 2023 | $10.04 Billion | -3.58% |
| 2022 | $10.41 Billion | +3.35% |
| 2021 | $10.07 Billion | -7.98% |
| 2020 | $10.95 Billion | +7.43% |
| 2019 | $10.19 Billion | -45.48% |
| 2018 | $18.69 Billion | +7.00% |
| 2017 | $17.47 Billion | -69.07% |
| 2016 | $56.48 Billion | -14.27% |
| 2015 | $65.88 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Teva Pharmaceutical Industries Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.18 Billion USD |
| MoneyControl | $17.18 Billion USD |
| MarketWatch | $17.18 Billion USD |
| marketcap.company | $17.18 Billion USD |
| Reuters | $17.18 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.